A new explanation for why some people are in long-term pain says it could be caused by the immune system attacking the person ...

The Pain Management Unit at Quirónsalud Torrevieja Hospital highlights the need to improve healthcare for patients living ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Fibromyalgia can take years to diagnose, and many healthcare providers still lack the tools to confidently identify it. This ...

Shan critiqued several factors of the study, including use of Patient Global Impression of Change (PGIC) for the primary endpoint, the statistical analysis, the control group selection, and ...

The FDA rejected Axsome's AXS-14 fibromyalgia, prompting a new trial and pushing the expected drug launch to 2028.

FDA concluded that AXS-14’s New Drug Application was not sufficiently complete for substantive review, citing concerns with one of two clinical trials in fibromyalgia patients.

Researchers hope the breakthrough will lead to new treatments for conditions such as fibromyalgia and rheumatoid arthritis.

It's heart-warming every time to see the relief and a smile on someone's face, knowing that others understand what they are ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...

The Cleveland Clinic recommends that people with POTS consume 3,000 to 10,000 mg of sodium per day to help maintain blood ...

Examples include chronic fatigue syndrome, lupus, mental illness, Crohn’s disease and fibromyalgia. Fibromyalgia is a long term (chronic) condition that causes widespread pain in the muscles ...